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Abstract
Background and objectives: Malaria, a parasitic protozoan disease caused primarily by Plasmodium falciparum, has killed
millions of people in Africa, particularly those with meager or no access to orthodox medical facilities and therapies.
Extracts from the Azadirachta indica (neem) plant is believed to possess antimalaria properties among the locals that rely
on herbs. Numerous in - vivo studies have suggested the antimalarial properties of neem extract and phytochemicals.
This study employs an in - silico method through molecular docking techniques to provide insight while adding
credence to the antimalarial potential of phytochemicals of neem plants as claimed in folkloric medicine.
Methods: e The crystal structure of P. falciparum a causative parasite of malaria was retrieved from the Protein Data
Bank, and Azadirachta indica phytochemicals were obtained from the PubChem database. Molecular docking through
virtual screening was carried out on the characterized phytochemicals. The bioactive compounds from the Azadirachta
indica plant were investigated by docking with the crystal structure of P. falciparum receptor and compared with
standard antimalarial drugs (lumenfrantrine and artemisinin).
Results: Three Azadirachta indica phytochemicals (gedunnin, nimbinene and salanin) shows a competing binding
energy and afﬁnity when compared to the approved antimalarial drugs (lumefrantrine and artemisinin). While the
binding afﬁnities for azadirachtin, nimbandiol and quercetin is lower than the afﬁnity in artemisinin but comparable
with lumefrantrine.
Conclusion: This virtual screening veriﬁed and identiﬁed a potential phytochemical component of antimalarial properties against a protein target: 1m7o, P. falciparum triosephosphate isomerase (PfTIM).
Keywords: In silico, Azadiracta indica, Plasmodium falciparum, Phytochemical, 3-Phosphoglycerate (3 PG)

1. Introduction

M

alaria is a major global public health problem. Six Plasmodium species can infect
human with Plasmodium falciparum being the most
frequent, virulent and lethal species among the
malarial parasites which accounts for ninety one
percent (91%) of malaria cases worldwide of which
the majority (about 86%) occurs in the Africa region
(more prevalent in Sub-Saharan Africa) [1e4]. P.
falciparum is the agent of severe malaria and
responsible for most malarial deaths [2,5e7].
Malaria is a devastating transferrable and infectious disease that is transmitted through female

anopheles mosquito infected with Plasmodium species [6,8]. The vector, female anopheles mosquito
introduces the parasite that causes malaria into the
human blood through its saliva when feeding or
during a blood meal [8e11]. When the parasite get
into the human body in the form of sporozoites it
moves from the blood stream to the hepatocytes in
the liver where it mature, reproduce and multiply
asexually over the next 7e12 days, during this time
there are no symptoms [6,8,12]. The parasites now in
the form of merozoites, leaves the liver cells (in
vesicle) to the bloodstream after traveling through
the heart to the capillaries of the lungs [8,12]. The
vesicles eventually disintegrate and release the
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merozoites to enter the bloodstream where it invades and multiply in the erythrocytes [8]. Clinical
symptoms of malaria resulting for the invasion and
rapture of erythrocytes cell by merozoites include
fever, chills, headache, vomiting, muscle ache, respiratory distress, cough, anorexia, rigor, diarrhea,
severe anemia, abdominal discomfort, thrombocytopenia, seizures, hypoglycemia, metabolic acidosis,
hyperlactemia, coma associated with increased
intracranial pressure (cerebral malaria), and complications of pregnancy, which include preterm
birth and low birth weight due to fetal growth restriction [6,8,13,14].
In some infected blood cells, instead of replicating
asexually, the merozoites develop into sexual forms
(gametocytes), which circulate in the bloodstream
and are ingested during mosquito bites. The ingested gametocytes develop in the mosquito into
mature sex cell (gametes) which later develop into
ookinetes that actively burrow through the mid-gut
of the mosquito and form oocysts, which further
develop into thousands of active sporozoites. The
oocyst eventually bursts, releasing sporozoites that
travel to the salivary glands of the mosquito, the
cycle of human infection begins again when the
mosquito bites another person [4,8].
P. species infection vary in severity depending on
the species and host factors, the host factor include
the level of host immunity, which is linked to the
past infection of Plasmodium parasite [6,15,16]. Plamodium ovale and Plasmodium vivax have dormant
forms (called hypnozoites) which can emerge from
the liver years after the initial infection, which can
lead to relapse if not treated properly [6,17]. In P.
falciparum, but not other P. species that affect human
malarias, the transition to gametocytogenesis is
delayed and the peak of gametocytaemia is 7e10
days after that of asexual parasitaemia, blood-stage
infection can persist for months or years in P. falciparum infections when untreated [10]. In tropical
regions, P. vivax relapses typically every 3e4 weeks.
In temperate areas, P. vivax can remain latent for
8e10 months between primary infection and ﬁrst
relapse [18] . Recurrent P. falciparum and vivax malaria have pronounced adverse effects in young
children and interfere with growth, development
and schooling [10].
The development of drug in P. falciparum (most
especially drug resistance) strains has stimulated
considerable interest in the search for new antimalarial drugs and drug targets [7]. Natural products
offers a wide range for drug discovery to cure diseases and drug resistance disease [19e21]. Phytochemical from Azadirachta indica has been
documented to possess many pharmacological

activities against numerous diseases most especially
it anti-malarial properties [22]. This present study is
to assess the in-silico antimalarial properties of the
phytochemicals from Azadirachta Indica.
Azadirachta indica (Neem), of the family Meliaceae,
commonly called dogonyaro in some parts of
Nigeria, is an evergreen plant native to India, where
it is known as divine tree or life-giving tree. It is
commonly found in America but is more endemic to
tropical and subtropical regions. It is a tall tree with
a height ranging between 20 and 40 m with scaly
and hard bark, alternating branches and leaves,
small white ﬂowers, and green drupes fruits that
turn yellowish when ripening. Its ﬂowering and
fruiting seasons range between the months of
MayeJune and JuneeAugust respectively [23,24].
The taxonomical classiﬁcation is as indicated in
Table 1.
Compounds that exhibited bioactivities such as
antioxidant, antiviral, antimicrobial, anti-inﬂammatory, antiulcer and antifungal activities have been
isolated from leaves, bark, roots, fruit and seeds of
Azadirachta indica. Its pharmacological activities are
due to the presence of alkaloids, ﬂavonoids, saponins, terpenes, tannins, and phenols [23,25,26]. The
most reported and bioactive constituents in Azadirachta indica (Table 2) are azadirachtin, gedunin,
nimbandiol, nimbin, nimbinene, nimbolide, nimbolinin, nimbidin, salannin and quercetin [24,26e28].

2. Materials and method
2.1. Computational platform and software
All computation analyses were performed on an
Acer ES1-131-C271, Windows 10 Home Single
Language 64-bit operating system, Intel Celeron
N3150 @ 1.6 GHz 8.00 GB RAM. Software used for
the screening are; OpenbabeL, PyRx, AutoDock4,
AutoDock Vina, PyMOL, LigPlot þ Version 2.2.5
and Discovery Studio.
Table 1. Botanical taxonomic of neem plant.
Taxonomy

Classiﬁcation

Order
Suborder
Family
Subfamily
Tribe
Genus
Species
Latin
Indian
Hindi
Hausa
Igbo

Rutales
Retinae
Meliaceae
Melioideae
Melieae
Azadirachta
indica
Azadirachta indica
Holy tree
Neem, Nim
Dogonyaro
Ogwu Akuma
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Table 2. Phytochemical constituents of Azadirachta indica and reported biological activities.
Phytochemical

Class of compound

Activities

Reference

Azadirachtin
Gedunin
Nimbandiol
Nimbine
Nimbinene
Nimbolide
Salannin
Quercetin
Nimbidin

tetranortriterpenoid
Limonoid tetranortriterpenoid
pentanortriterpenoids
Triterpenoid
pentanortriterpenoids
tetranortriterpenoids
pentanortriterpenoids
Polyphenolic ﬂavonoid

Anticancer, antimalarial
Anticancer, antimalarial

[27,29,30]
[22,27,31]
[27]
[27]
[27]
[27,32]
[27]
[27]
[33]

Openbabel was used to convert ﬁle to PDB ﬁle
format, PyRx was used to minimized the energy and
prepare the ligand, AutoDock4 was used in protein
preparation and to obtain the grid parameter of the
protein, AutoDock Vina was used to execute the
virtual screening in CMD, PyMOL was used to
export ligand and protein into ligand-protein complex, LigPlotþ was used to obtain the two dimension
(2-D) ligand-protein interactions, Discovery Studio
was used to view the three dimension (3-D)
ligandeprotein interactions.
2.2. Retrieval of ligand and preparation
Azadirachta indica phytochemicals with potent
antimalarial properties and available at the NCBI
Pub Chem Compounds data bank (https://
pubchem.ncbi.nlm.nih.gov/) were considered for
this study.
The two-dimensional (2D) structures of the
selected phytochemicals, approved drugs and the
co-crystallized ligand were obtained in the simple
data ﬁle (sdf) from the NCBI Pub Chem Compounds
data bank (https://pubchem.ncbi.nlm.nih.gov/) and
were converted into pdb ﬁle format using Openbabel in PyRx [34]. The ligands (3-Phosphoglycerate,
phytochemicals and approved drugs) were further
prepared for molecular docking by minimizing the
energy in PyRx using mmff94 energy minimization
parameter following the method described in Dallakyan and Olson 2015 with slight modiﬁcation [35].
The ligand details are indicated in Table 3.
2.3. Retrieval of protein, active site prediction and
preparation
The crystal structure of P. falciparum triosephosphate isomerase (PfTIM) provides an insights into antimalarial drug discovery and design
[36], this crystal structure complied with substrate
analog 3-phosphoglycerate (3 PG), PDB Code:
1M7O (Fig. 1) available at RCSB Protein Data Bank

Anti-inﬂammatory, antipyretic, antiseptic
Anticancer, antimalarial, antibacterial

Anti-inﬂammatory, anti-fungal, antibacterial

possess a basic structural representation for others
PfTIM crystals. The three-dimensional (3-D) X-ray
crystal structure of the protein P. falciparum triosephosphate isomerase (PfTIM) with the native 3phosphoglycerate (3 PG), PDB Code: 1M7O obtained through X-ray diffraction with a resolution of
2.40 Å used in this study was retrieved from the
RCSB Protein Data Bank.
The crystal structure of P. falciparum triosephosphate isomerase (PfTIM) has two active
sites (chain A and Chain B). Therefore, for detailed
docking and better analysis the chains were separated. The receptor chains were split and prepared
for molecular docking in AutoDock4 by the removal
the water molecules, the co-crystallized ligand and
other heteroatoms (Fig. 2). The missing residue was
repaired, histidine hydrogen was added, polar
hydrogen was added, converted to AD4 type and
the grid dimension around the active site (residues
bounded to the native ligands) was obtained using
AutoDock4 following the protocol described in Ravi
and Krishnan 2016 with slight modiﬁcation [37]. The
grid dimension around the active site was obtained
in AutoDock4 and site values for the crystal structure of P. falciparum triosephosphate isomerase
(PfTIM) subunit A and B used in this docking are
given in Table 4.
2.4. In silico molecular docking and validation of
docking
The docking setting for this virtual screening was
validated by re-docking the native ligand into
crystal structure of P. falciparum triosephosphate
isomerase (PfTIM-Chain A and Chain B separately)
and interactions were compared with un-dock
crystal structure of P. falciparum triosephosphate
isomerase in subunit A and B chains.
The virtual screening was processed to estimate
the binding afﬁnities and interaction of the ligands
(phytochemicals, approved drugs and 3-Phosphoglycerate) against prepared crystal structure of P.

13

AL-BAHIR JOURNAL FOR ENGINEERING AND PURE SCIENCES 2022;1:10e24

Table 3. Drugs and phytochemical details.
Drug/Compound

Pubchem CID

Molecular formula

Molecular weight

3-Phosphoglycerate

724

C3H7O7P

186 g/mol

Lumefantrine
Approved drug

6437380

C30H32NOCl3

528 g/mol

Artemisinin
Approved drug

68827

C15H22O5

282 g/mol

Azadirachtin

5281303

C35H44O16

720 g/mol

Gedunin

12004512

C28H34O7.

482 g/mol

Nimbandiol

157277

C26H32O7

456 g/mol

Nimbinene

44715635

C28H34O7

482 g/mol

Quercetin

5280343.

C15H10O7

302 g/mol

Structure

(continued on next page)
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Table 3. (continued )
Drug/Compound

Pubchem CID

Molecular formula

Molecular weight

Salanin

6437066

C34H44O9.

596 g/mol

Structure

Table 4. Docking grid for the crystal structure of PfTIM.
Chain

Spacing

Dimensions (Npts)

Center

A

0.375

B

0.375

X
Y
Z
X
Y
Z

X
Y
Z
X
Y
Z

-

50
52
38
40
40
50

-

8.361
13.389
23.556
19.528
-14.139
22.056

3. Results
3.1. Docking setting validation

Fig. 1. Crystal structure of Plasmodium falciparum triosephosphate
isomerase (PfTIM) with native ligand 3-Phosphoglycerate (Discovery
Studio-schematic display style).

falciparum triosephosphate isomerase (PfTIM). Trott
and Olson 2009 methods were adopted in the virtual
screening with slight modiﬁcation [38]. For high
accuracy and reliability, this in silico study uses an
exhaustiveness of ten in the molecular docking
procedure.

Validation was performed by re-docking the
native ligand into the crystal structure of P. falciparum triosephosphate isomerase (PfTIM-chain A and
Chain B) and superpose with the original-undock
crystal structure of P. falciparum triosephosphate
isomerase. The interaction, pose and superpose
were visualized in LigPlot þ for its validity
(Fig. 3a and 3b).
The superpose image obtained in Fig. 3a(iii) and
Fig. 3b(iii) shows a comparative and reliable validation for the docking procedure adopted for this

Fig. 2. Crystal structure of Plasmodium falciparum triosephosphate isomerase (PfTIM) chain A and chain B (Discovery Studio-schematic display
style).
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Fig. 3a. Crystal structure of Plasmodium falciparum triosephosphate isomerase (PfTIM) A subunit with (i) redock native ligand (ii) native ligand
(iii) superimposed complexes (redock native ligand-PfTIM complex and native ligand-PfTIM complex).

virtual screening. For complexes (redocked and
undock) obtained in PfTIM A subunit, the protein
residues; ASN10, LYS12, HIS95, SER211, LEU230,
GLY232 and ASN233 superpose well (Fig. 3a). Also,
the protein residues; ASN10, LYS12, HIS95, GLY209,
LEU230, VAL231 and GLY232 generated in PfTIM B
subunit complexes superimpose properly (Fig. 3b)
with few exceptions.

The ligand conformation with the best docking
value was combined with the prepared PfTIM in
PyMOL, the 2-dimension (2-D) and 3-dimension (3D) visual interactions were obtained in LigPlotþ and
Discovery Studio respectively. All visual interactions
for all screening ligands are shown in Supplementary
ﬁgures (Fig. 5) at the Appendix section.
3.3. Bond interaction and afﬁnity comparison

3.2. Docking (virtual screening)
From the docking-screening process using AutoDock Vina command prompt with the vina_windows.pl script, only the best or top ranked
docked complexes were extracted from the result
generated from the virtual screening. The main
interaction, bonds category and types between the
ligand and the protein were obtained in the nonbond section in Discovery Studio (Table 5).

Bond interactions (electrostatic, hydrogen and
hydrophobic) enhance the binding afﬁnity and
biological activity of complex molecules and help in
stabilizing the biochemical environment of
targetedrug complexes, also ligand-protein interaction with more hydrogen bond tend to form a
stronger complex with high binding afﬁnity [39e41].
From the binding energy value (Table 5), the
binding afﬁnities of the crystal structure of PfTIM

Fig. 3b. Crystal structure of Plasmodium falciparum triosephosphate isomerase (PfTIM) B subunit with (i) redock native ligand (ii) native ligand
(iii) superimposed complexes (redock native ligand-PfTIM complex and native ligand-PfTIM complex).

COMPOUND

3-phospho
Glycerate
(3 PG)

Artemisinin
(ART)

Azadirachtin
(AZA)

PfTIM CHAIN A

PfTIM CHAIN B

Energy/afﬁnity Interaction
(kcal/mol)

Bond Category

Type

Energy/afﬁnity Interaction
(kcal/mol)

4.9

LYS12:NZ - 3 PG:O

Hydrogen

Conventional

4.9

6.5

HIS95:HE2 - 3 PG:O
GLY232:HN - 3 PG:O
3 PG:H - LEU230:O
3 PG:H - LEU230:O
3 PG:H - SER211:OG
3 PG:H - GLY210:O
GLU238:OE2 - LUM

Hydrogen
Hydrogen
Hydrogen
Hydrogen
Hydrogen
Hydrogen
Electrostatic

Conventional
Conventional
Conventional
Conventional
Conventional
Conventional
Pi-Anion

7.3

SER19:CB - LUM
LUM:C - LEU236
LUM:C - LYS237
LUM:Cl - ILE20
LUM:Cl - LEU23
LUM:Cl - LEU236
TRP11 - LUM:Cl
LUM - LEU23
LUM - LEU236
LUM - LEU23
LYS12:NZ - ART:O

Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrogen

Pi-Sigma
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl
Conventional

6.9

GLY232:HN - ART:O
ALA234 - ART:C
ART - ILE170
ART:C - ILE170
HIS95 - ART:C
PHE96 - ART:C
PHE96:HO - AZA:O

Hydrogen
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrogen

Conventional
Alkyl
Alkyl
Alkyl
Pi-Alkyl
Pi-Alkyl
Conventional

ARG99:HH11 - AZA:O
GLN133:HE21 - AZA:O
GLN146:NE2 - AZA:O
AZA:H - ASP106:OD2

Hydrogen
Hydrogen
Hydrogen
Hydrogen

Conventional
Conventional
Conventional
Conventional

ARG99:CD - AZA:O
VAL142 - AZA
LYS145 - AZA
AZA - VAL142
AZA - LYS145
AZA:C - LYS100
AZA:C - LEU167

Hydrogen
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic

Carbon Hydrogen
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl

Bond Category

Type

ASN10:HD21 - 3 PG:O Hydrogen

Conventional

Hydrogen
HIS95:HE2 - 3 PG:O
Hydrogen
3 PG:P - LEU230:O
3 PG:H - GLU165:OE2 Hydrogen

Conventional
Conventional
Conventional

6.4

LUM:C - ASN65:OD1

Hydrogen

Carbon Hydrogen

6.8

ARG98:NH1 - LUM
PHE102 - LUM
LUM:C - VAL78
LUM:Cl - VAL44
LUM:Cl - ARG98
HIS95 - LUM:Cl
LUM - CYS13
LUM - VAL44
LUM - CYS13
LUM - ARG98
ART:C - ILE63

Electrostatic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic

Pi-Cation
PiePi Stacked
Alkyl
Alkyl
Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl
Alkyl

ART:C - VAL78

Hydrophobic

Alkyl

7.1

ARG99:HH11 - AZA:O Hydrogen

Conventional

Hydrogen
ASP106:HN - AZA:O
GLN133:NE2 - AZA:O Hydrogen

Conventional
Conventional

GLN146:NE2 - AZA:O
AZA:C - GLY128:O
AZA:C - ILE170:O
LEU167 - AZA

Hydrogen
Hydrogen
Hydrogen
Hydrophobic

Conventional
Carbon Hydrogen
Carbon Hydrogen
Alkyl
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Lumefantrine
(LUM)

16

Table 5. The interactions of ligands with PfTIM from the docking evaluation.

Gedunin (GED) 8.0

Nimbandiol
(NIML)

Quercetin
(QUE)

Salannin (SAL)

ARG99:HH11 - GED:O Hydrogen
ASP106:HN - GED:O Hydrogen
Hydrogen
ARG99:CD - GED:O

7.6

NIML:H - GLY209:O

Hydrogen

Conventional

Alkyl

LYS237:NZ - NIML

Hydrogen;
Electrostatic

Attractive Charge 7.8

Hydrophobic
ALA234 - NIML
Hydrophobic
NIML:C - ILE170
ARG98:NH1 - NIME:O Hydrogen

Pi-Cation; Pi-Donor
Hydrogen
Alkyl
Alkyl
Conventional

Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Electrostatic

Pi-Sigma
Alkyl
Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Cation

ALA234 - NIML

Hydrophobic

Conventional
Conventional
Carbon Hydrogen

8.4

ARG98:NH1 - NIME:O Electrostatic
Hydrogen
Hydrogen
Hydrogen
Hydrophobic
Hydrophobic
Hydrophobic
Hydrogen

Conventional
Carbon Hydrogen
Carbon Hydrogen
Alkyl
Pi-Alkyl
Pi-Alkyl
7.1
Conventional

ARG98:HD1 - NIME:O
NIME:C e CYS13
HIS95 - NIME:C
PHE102 - NIME:C
NIME - VAL78

Hydrogen
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic

Carbon Hydrogen
Alkyl
Pi-Alkyl
Pi-Alkyl
Pi-Alkyl

7.2

ARG98:NH1 - NIME:O
ARG98:HD1 - NIME:O
NIME:C - GLN64:O
NIME:C e CYS13
PHE102 - NIME:C
NIME - VAL78
QUE:H - ASN65:O

QUE:H - ASN65:O

Hydrogen

Conventional

QUE:H e HIS95:ND1

Hydrogen

Conventional

ARG98:NH1 - QUE

Hydrogen; Electrostatic Pi-Cation; Pi-Donor

QUE:H - GLU97:OE1
ARG98:NH1 e QUE

Hydrogen
Conventional
Hydrogen; Electrostatic Pi-Cation; Pi-

ARG98:NH1 - QUE
QUE - ARG98

Electrostatic
Hydrophobic

Hydrogen
Pi-Cation
Pi-Alkyl

ARG98:NH1 e QUE
QUE - ARG98
LYS145:HZ1 - SAL:O
LEU167:CD1 - SAL
ARG99 - SAL
SAL:C - ARG99
SAL:C - LEU167
SAL:C - VAL142
SAL:C - LYS145
SAL - LYS100

Electrostatic
Hydrophobic
Hydrogen
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic

GLN133:NE2 - SAL:O
LYS145:CE - SAL:O

Hydrogen
Hydrogen

Conventional
Carbon Hydrogen

LYS100:NZ - SAL
LEU167:CD1 - SAL
ARG99 - SAL
LYS100 - SAL
SAL:C - ARG99
SAL:C - LEU167
SAL:C - VAL142
SAL:C - LYS145
SAL - LYS100

Electrostatic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic
Hydrophobic

Pi-Cation
Pi-Sigma
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl
Pi-Alkyl

7.7

Donor Hydrogen
Pi-Cation
Pi-Alkyl
Conventional
Pi-Sigma
Alkyl
Alkyl
Alkyl
Alkyl
Alkyl
Pi-Alkyl

7.1
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Nimbinene
(NIME)

7.2

7.8

GED:C - PHE102
GED:C - VAL44
GED:C e CYS13
GED - ILE63
GED - VAL78
LYS237:NZ - N:NIML
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Table 6. Nimbandiol- PfTIM bonds and energy comparison.
Complex

Nimbandiol- PfTIM subunit A

Energy
Bonds
Number

7.2 kcal/mol
Electrostatic
1

Hydrogen
e

Nimbandiol- PfTIM subunit
7.6 kcal/mol
Electrostatic
1

hydrophobic
1

Hydrogen
2

hydrophobic
2

Table 7. Gedunin nimbinene, salanin and artemisnin bond afﬁnities with PfTIM subunit A.
Compound

Artemisnin

Gedunin

Nimbinene

Salanin

Binding energy (kcal/mol)
Electrostatic (attractive
charge) bond
Electrostatic (Pi-cation)
Hydrogen (Conventional)
bond
Hydrogen (Carbon) bond
Hydrophobic (Alkyl) bond
Hydrophobic (Pi-Alkyl)
bond
Hydrophobic (Pi-Sigma)
bond
Total interactions

7.3
e

8.0
e

8.4
1

7.7
e

e
2

e
e

e
1

e
1

e
3
2

e
2
2

2
1
2

e
5
1

e

1

e

e

7

5

7

7

subunits with a particular ligand is dependent on
the number of bonds or interactions; geduninPfTIM A subunit (8.0 kcal/mol) ﬁve interactions
and gedunin-PfTIM B subunit (7.8 kcal/mol) three
interactions,
nimbandiol-PfTIM
A
subunit
(7.2 kcal/mol) two interactions and nimbandiolPfTIM B subunit (7.6 kcal/mol) four main interactions, nimbinene-PfTIM A subunit (8.4 kcal/
mol) seven interactions and nimbinene-PfTIM B
subunit (7.8 kcal/mol) six interactions, quercetinPfTIM A subunit (7.2 kcal/mol) six interactions
and quercetin-PfTIM B subunit (7.1 kcal/mol) four
main interaction. However, this trend was not seen
in salanin and azadirachtin, difference in binding
energy may be due to other factor apart from the
number of interactions.
Ligand-protein interaction that show a binding
afﬁnity which depends on the nature of bonds

between the ligand and the subunits crystal structure of PfTIM is nimbandiol, with binding value of
7.2 kcal/mol in PfTIM subunit A and 7.6 kcal/mol
PfTIM subunit B (Table 6).
Finally, nimbinene has the highest docking value
with binding afﬁnities of 8.4 kcal/mol in PfTIM
subunit A, this may be due to present of electrostatic
bond through attractive charge, as it is the only
phytochemical and ligand that possess this type of
electrostatic bond in this study.
3.4. Ligand comparison and promising
phytochemical
The amino residue interactions in some ligandprotein complexes of this study were also found in
the research work of Parthasarathy et al., (2002) in
which it was reported that the active-site of the

Table 8. Gedunin nimbinene, salanin and artemisnin bond afﬁnities with PfTIM subunit B.
Compound

Artemisinin

Gedunin

Nimbinene

Salanin

Binding energy (kcal/mol)
Electrostatic (attractive
charge) bond
Electrostatic (Pi-cation)
Hydrogen (Conventional)
bond
Hydrogen (Carbon) bond
Hydrophobic (Alkyl) bond
Hydrophobic (Pi-Alkyl)
bond
Hydrophobic (Pi-Sigma)
bond
Total interaction

6.8
e

7.8
e

7.8
e

7.1
e

e
e

e
2

e
1

1
1

e
2
e

1
e
e

1
1
3

1
6
1

e

e

e

e

2

3

6
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crystal structure of PfTIM are LYS12, HIS95,
GLU165 and that the interaction of ligand atom 3phosphoglycerate (3 PG) occurs at amino residues
ASN10, LYS12, HIS95, GLU165, and LEU230 protein
residue of PfTIM [42]. The protein residue interaction (of Azadirachta indica Phytochemical-crystal
structure of PfTIM) in this study which are also
found in the work of Parthasarathy et al., (2002) are;
HIS95 subunit B e Lumefantrine:Cl, LYS12:NZ
subunit A - Artemisinin:O, HIS95 subunit A Artemisinin:C, HIS95 subunit B - Nimbinene:C and
Quercetin:H e HIS95:ND1 subunit A . The amino
residue HIS95 is predominant, which is a residue on
the active site of the crystal structure of PfTIM
subunit A and B.
The binding afﬁnities of the approved antimalarial
drug (Table 5), shows that artemisinin has a better
binding afﬁnity than its counterpart lumefantrine in
subunit A and B of the crystal structure of PfTIM,
which supports and conﬁrms that artemisinin-based
combination therapy is more effective in the treatment of malaria than lumefantrine-based combination therapy [43]. In subunit A PfTIM the binding
afﬁnity of lumefantrine is 6.5 kcal/mol while
artemisinin is 7.3 kcal/mol, this may be due to the
interaction of artemisinin with some of the protein
residue at the active site of the crystal structure of
PfTIM; LYS12:NZ - Artemisinin:O and HIS95 Artemisinin:C.
All the screen phytochemical shows a high binding afﬁnity than lumefantrine which may indicate
that all the phytochemical can be a good substitute
to this drug. Azadirachtin, nimbandiol and quercetin show a comparative binding energy with
artemisinin at subunit A and B crystal structure of
PfTIM. Gedunin, nimbinene and salanin show a
relative high binding afﬁnity than artemisinin which
will be consider for further discussion based the
nature of the bond category and type (Table 7 and
Table 8).
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The electrostatic (attractive charge) bond and hydrophobic (Pi-sigma) bonds present in nimbinenePfTIM subunit A and gedunin-PfTIM subunit A
respectively may be responsible for its high binding
afﬁnities (Table 7).
In the ligand-protein interactions in crystal
structure of PfTIM subunit B, less number of interactions and the absence of strong force of interactions (electrostatic and hydrogen bond) may be
responsible for the low binding afﬁnity in artemisinin (Table 8).

4. Conclusion
In conclusion, most of the investigated phytochemicals from Azadirachta indica exhibited
comparative antimalarial activities against 1m7o:
Plasmodium falciparum trisephosphate isomerase
(PfTIM). The ﬁndings in this work further add
credence to the claim that Azadirachta indica extracts
are potent against malaria infection. Further in vivo
studies are recommended for the evaluation of each
phytochemical and their synergistic antimalarial
effects.
Likewise, there is also the need to further investigate other reported isolates of Azadirachta indica
against other species of causative enzyme of malaria
to underscore the mechanism of action, molecular
dynamic and validate the potency of the phytochemicals as antimalarial agent(s).

Source of funding
This research did not receive any grants or funds
from funding agencies in the commercial, public or
not-for-proﬁt sector.

Conﬂict of interest
The authors have no conﬂicts of interest.

20

AL-BAHIR JOURNAL FOR ENGINEERING AND PURE SCIENCES 2022;1:10e24

Appendix

Supplementary Fig. 5. 2-dimension (2-D) and 3-dimension (3-D) visual interactions in LigPlotþ and Discovery Studio respectively.
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Supplementary Fig. 5. (Continued).
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Supplementary Fig. 5. (Continued).
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